Fox Chase Cancer Center News

PHILADELPHIA (February 15, 2017) – Dr. Finestone, will start at the Center’s department of medicine on February 15, 2017.

PHILADELPHIA (February 8, 2017) – The Fox Chase-Temple University Hospital Bone Marrow Transplant Program has received internationally-recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for adult allogeneic and autologous hematopoietic progenitor cell transplantation, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation. 

PHILADELPHIA (February 2, 2017) – In the largest study of its kind to date, researchers from Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University confirmed that oral antibiotics combined with mechanical bowel preparation were more effective at preventing surgical site infections after elective colorectal surgery compared to no bowel preparation or use of mechanical bowel preparation alone. Nestor F. Esnaola, MD, MPH, professor of surgical oncology at Fox Chase, led the study, which appears in Annals of Surgery.

PHILADELPHIA (February 2, 2017) – Eric D. Tetzlaff, MHS, a physician assistant at Fox Chase Cancer Center, has been recognized as a Distinguished Fellow of the American Academy of Physician Assistants (AAPA) for his outstanding contributions to patient care and the profession. 

PHILADELPHIA (February 1, 2017) – A board-certified radiation oncologist, Howell will start at Fox Chase on February 1, 2017.

PHILADELPHIA (January 31, 2017) – A team of researchers at Fox Chase Cancer Center has found that stroma – a tumor-associated niche containing noncancerous cells and extracellular proteins – carries a cellular signature indicating whether it is likely to promote or restrict the tumor’s growth. 

PHILADELPHIA (January 20, 2017) – A team of researchers at Fox Chase Cancer Center found that, despite the recommendation of screening guidelines, less than half of adults younger than 50 years old who have colorectal cancer are being screened for Lynch Syndrome, a genetic anomaly that increases the risk of colorectal and several other forms of cancer.

PHILADELPHIA (January 18, 2017) – Fox Chase Cancer Center is pleased to announce the results of its American Cancer Society Institutional Research Grant (IRG) Pilot Project Competition for Junior Investigators, Yibin Yang, PhD, Matthew R. Zibelman, MD, and Namrata (Neena) Vijayvergia, MD.